Joined Today: 3

NEOP Neoprobe, Stock Message Board

All Messages

NEOP Message Board Home | Join The NEOP Group |

#36: NEOP News Neoprobe Introduces Bluetooth Wireless Probe
Stock News Bot	October 9, 2006 01:04:00 PM
DUBLIN, Ohio--(BUSINESS WIRE)--Neoprobe Corporation (OTCBB:NEOP), a diversified developer of innovative oncology and cardiovascular surgical and diagnostic products, today announced... view message ignore post recommend post

#35: NEOP News CORRECTING and REPLACING Neoprobe to Present at Wall Street Analyst Forum; CFO To Provide Business Update
Stock News Bot	September 27, 2006 08:10:00 AM
DUBLIN, Ohio--(BUSINESS WIRE)--Please replace the release dated September 21, 2006 with the following corrected version due to multiple revisions to the headline and text. ... view message ignore post recommend post

#34: NEOP News Neoprobe to Present at Bio CEO Conference; CEO to Provide Business Update
Stock News Bot	September 21, 2006 01:01:00 PM
DUBLIN, Ohio--(BUSINESS WIRE)--Sept. 21, 2006--Neoprobe Corporation (OTCBB:NEOP), a diversified developer of innovative oncology and cardiovascular surgical and diagnostic products, today announced... view message ignore post recommend post

#33: NEOP News ESTECH Signs Expanded Distribution Agreement With Neoprobe; ESTECH to Distribute Quantix Blood Flow Devices in Europe and U.S.
Stock News Bot	September 11, 2006 02:00:00 AM
STOCKHOLM, Sweden--(BUSINESS WIRE)--Sept. 11, 2006--At the 5th EACTS (European Association for Cardio-Thoracic Surgery) Meeting, ESTECH, Inc., of San Ramon, CA, announced it has expanded the... view message ignore post recommend post

#32: NEOP News Dutton Associates Announces Investment Opinion: Neoprobe Rating Raised To Speculative Buy By Dutton Associates
Stock News Bot	September 6, 2006 09:30:00 AM
EL DORADO HILLS, Calif.--(BUSINESS WIRE)--Sept. 6, 2006--Dutton Associates continues coverage of Neoprobe Corporation (OTCBB:NEOP), upgrading its rating to speculative buy with a new price target... view message ignore post recommend post

#31: NEOP News Neoprobe Announces Second Quarter Results; Business Update Provided and Conference Call Scheduled
Stock News Bot	August 2, 2006 05:30:00 AM
DUBLIN, Ohio--(BUSINESS WIRE)--Aug. 2, 2006--Neoprobe Corporation (OTCBB:NEOP), a diversified developer of innovative oncology and cardiovascular surgical and diagnostic products, today announced... view message ignore post recommend post

#30: NEOP News Neoprobe Interviewed by WallSt.net; CFO Provides Business Update
Stock News Bot	July 31, 2006 01:58:00 PM
DUBLIN, Ohio--(BUSINESS WIRE)--July 31, 2006--Neoprobe Corporation (OTCBB:NEOP), a diversified developer of innovative oncology and cardiovascular surgical and diagnostic products, today announced... view message ignore post recommend post

#29: NEOP News Neoprobe 2nd Quarter 2006 Earnings Conference Call Invitation; Conference Call Scheduled for 11:00 a.m., Wednesday, August 2, 2006
Stock News Bot	July 27, 2006 01:05:00 PM
DUBLIN, Ohio--(BUSINESS WIRE)--July 27, 2006--Neoprobe Corporation (OTCBB:NEOP), a diversified developer of innovative oncology and cardiovascular surgical and diagnostic products, today announced... view message ignore post recommend post

#28: NEOP News Neoprobe to Present at Friedland Investment Meetings; CEO To Provide Business Update
Stock News Bot	July 17, 2006 05:03:00 AM
DUBLIN, Ohio--(BUSINESS WIRE)--July 17, 2006--Neoprobe Corporation (OTCBB:NEOP), a diversified developer of innovative oncology and cardiovascular surgical and diagnostic products, today announced... view message ignore post recommend post

#27: NEOP News Neoprobe Initiates Lymphoseek Phase 2 Clinical Study
Stock News Bot	July 12, 2006 10:00:00 AM
DUBLIN, Ohio--(BUSINESS WIRE)--July 12, 2006--Neoprobe Corporation (OTCBB:NEOP), a diversified developer of innovative oncology and cardiovascular surgical and diagnostic products, today announced... view message ignore post recommend post

#26: NEOP News Dutton Associates Announces Investment Opinion: Neoprobe Neutral Rating Maintained By Dutton Associates
Stock News Bot	July 5, 2006 12:24:00 PM
EL DORADO HILLS, Calif.--(BUSINESS WIRE)--July 5, 2006--Dutton Associates continues coverage of Neoprobe Corporation (OTCBB:NEOP), maintaining its rating of neutral. The 11-page report by Dutton... view message ignore post recommend post

#25: NEOP News Neoprobe Completes Regulatory Submission for Lymphoseek; Neoprobe Files Non-Clinical Response With FDA
Stock News Bot	December 21, 2005 06:47:00 AM
DUBLIN, Ohio--(BUSINESS WIRE)--Dec. 21, 2005--Neoprobe Corporation (OTCBB:NEOP), a diversified developer of innovative oncology and cardiovascular surgical and diagnostic products, today announced... view message ignore post recommend post

#24: NEOP News Neoprobe's Lymphoseek Issued European Patent; Neoprobe Licensed Product Patent Covers Major European Markets
Stock News Bot	November 15, 2005 02:30:00 AM
DUBLIN, Ohio--(BUSINESS WIRE)--Nov. 15, 2005--Neoprobe Corporation (OTCBB:NEOP), a diversified developer of innovative oncology and cardiovascular surgical and diagnostic products, announced that... view message ignore post recommend post

#23: NEOP News Neoprobe Establishes Corporate IND for RIGScan CR; Neoprobe Assumes Corporate Responsibility for Clinical Evaluation
Stock News Bot	November 7, 2005 07:16:00 AM
DUBLIN, Ohio--(BUSINESS WIRE)--Nov. 7, 2005--Neoprobe Corporation (OTCBB:NEOP), a diversified developer of innovative oncology and cardiovascular surgical and diagnostic products, today announced... view message ignore post recommend post

#22: NEOP News Neoprobe Provides Third Quarter Results & Development Update; Conference Call Scheduled
Stock News Bot	November 3, 2005 02:30:00 AM
DUBLIN, Ohio--(BUSINESS WIRE)--Nov. 3, 2005--Neoprobe Corporation (OTCBB:NEOP), a diversified developer of innovative oncology and cardiovascular surgical and diagnostic products, today announced... view message ignore post recommend post

Group Home | Login if you want to post a message